Details

Proposal_Info
Status
Awarded
Identifier
11-173
Date of Proposal
12/9/2010
Action Date
6/29/2011
Funding Agency
Novartis Pharmaceuticals Corporation
Title
A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People - Aliskiren Prevention of Later Life Outcomes
Keyword_1
Hypertension
Keyword_2
Cardiovascular Disease
Keyword_3
Aliskiren
Type
New
Type of Award
Contract
Type of Project
Research
Start Date
3/1/2010
End Date
12/1/2017
Requested Amount
$664,615.00
Indirect Amount Requested
$132,923.00
Indirect Costs
Cost Share/Match
Release Time Requested
Human Subjects Involved
Animals Involved
Hazardous Chemicals Involved
Radiation Involved
Biohazards and/or Recombinant DNA/RNA Molecules
Real or Potential Conflict of Interest
New Program/Degree/Major
Future Equipment Maintenance Needed
Consultants or Subcontractors
Lobbying
Construction or Facilities Modification

Edit | Back to List